Substituted triazoles and pharmaceutical compositions containing the compoundsare disclosedas being useful in inhibiting the activity of the receptor protein tyrosinekinase Axl. Methods of using thecompounds in treating diseases or conditions associated with Axl activity,particularly diseases andconsitions associated with angiogenesis and/or cell proliferation, are alsodisclosed.